9-Jan-2026
TrueBlue Defends Strategy Amid EHS Director Nomination Challenge
TipRanks (Fri, 9-Jan 6:32 AM ET)
Business Wire (Thu, 8-Jan 5:31 PM ET)
EHS Announces Three Highly Qualified Director Nominees for Election to TrueBlue Board
PRNewswire (Thu, 8-Jan 9:45 AM ET)
Business Wire (Wed, 10-Dec 8:00 AM ET)
TrueBlue Appoints Two New Independent Directors
Business Wire (Tue, 2-Dec 11:59 AM ET)
EHS Announces Intent to Nominate Directors at Upcoming TrueBlue Annual Meeting
PRNewswire (Tue, 2-Dec 9:45 AM ET)
Business Wire (Mon, 17-Nov 8:00 AM ET)
TrueBlue Reports Third Quarter 2025 Results
Business Wire (Mon, 3-Nov 4:05 PM ET)
TrueBlue's PeopleReady Appoints New Sales Leadership to Further Advance Growth
Business Wire (Mon, 3-Nov 8:00 AM ET)
TrueBlue's Centerline Named a Top Company for Women to Work in Transportation
Business Wire (Thu, 30-Oct 8:00 AM ET)
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.
Trueblue trades on the NYSE stock market under the symbol TBI.
As of January 9, 2026, TBI stock price climbed to $4.81 with 181,527 million shares trading.
TBI has a beta of 1.06, meaning it tends to be more sensitive to market movements. TBI has a correlation of 0.10 to the broad based SPY ETF.
TBI has a market cap of $142.89 million. This is considered a Micro Cap stock.
Last quarter Trueblue reported $431 million in Revenue and $.03 earnings per share. This beat revenue expectation by $23 million and exceeded earnings estimates by $.12.
In the last 3 years, TBI traded as high as $20.60 and as low as $3.45.
The top ETF exchange traded funds that TBI belongs to (by Net Assets): FNDA, VTI, IWM, AVUV, VXF.
TBI has underperformed the market in the last year with a return of -36.5%, while the SPY ETF gained +19.0%. In the last 3 month period, TBI fell short of the market, returning -17.2%, while SPY returned +3.7%. However, in the most recent 2 weeks TBI has outperformed the stock market by returning +3.4%, while SPY returned +0.5%.
TBI support price is $4.40 and resistance is $4.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TBI shares will trade within this expected range on the day.